Table of Contents Author Guidelines Submit a Manuscript
BioMed Research International
Volume 2017, Article ID 6482842, 7 pages
https://doi.org/10.1155/2017/6482842
Research Article

Leptin-LepRb Expressed in Gastric Cancer Patients and Related to Cancer-Related Depression

1Department of Laboratory Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China
2Department of Hematology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China
3Department of Clinical Oncology, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
4Department of Clinical Laboratory, The First Affiliated Hospital, Xi’an Jiaotong University, Xi’an 710061, China
5Department of Radiation and Medical Oncology, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China

Correspondence should be addressed to Yongchang Wei; moc.361@8gnahcgnoyiew

Received 28 October 2016; Revised 12 January 2017; Accepted 22 January 2017; Published 20 February 2017

Academic Editor: Koichiro Wada

Copyright © 2017 Yunbao Pan et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Kuhnt, E. Brähler, H. Faller et al., “Twelve-Month and Lifetime Prevalence of Mental Disorders in Cancer Patients,” Psychotherapy and Psychosomatics, vol. 85, no. 5, pp. 289–296, 2016. View at Publisher · View at Google Scholar · View at Scopus
  2. S. Swartzman, J. N. Booth, A. Munro, and F. Sani, “Posttraumatic stress disorder after cancer diagnosis in adults: a meta-analysis,” Depression and Anxiety, 2016. View at Publisher · View at Google Scholar · View at Scopus
  3. M. Hernández Blázquez and J. A. Cruzado, “A longitudinal study on anxiety, depressive and adjustment disorder, suicide ideation and symptoms of emotional distress in patients with cancer undergoing radiotherapy,” Journal of Psychosomatic Research, vol. 87, pp. 14–21, 2016. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Cosci, G. A. Fava, and N. Sonino, “Mood and anxiety disorders as early manifestations of medical illness: a systematic review,” Psychotherapy and Psychosomatics, vol. 84, no. 1, pp. 22–29, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. M. Lloyd-Williams, C. Shiels, F. Taylor, and M. Dennis, “Depression—an independent predictor of early death in patients with advanced cancer,” Journal of Affective Disorders, vol. 113, no. 1-2, pp. 127–132, 2009. View at Publisher · View at Google Scholar · View at Scopus
  6. G. Pelletier, M. J. Verhoef, N. Khatri, and N. Hagen, “Quality of life in brain tumor patients: the relative contributions of depression, fatigue, emotional distress, and existential issues,” Journal of Neuro-Oncology, vol. 57, no. 1, pp. 41–49, 2002. View at Publisher · View at Google Scholar · View at Scopus
  7. L. Yang, “Incidence and mortality of gastric cancer in China,” World Journal of Gastroenterology, vol. 12, no. 1, pp. 17–20, 2006. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Nordin and B. Glimelius, “Psychological reactions in newly diagnosed gastrointestinal cancer patients,” Acta Oncologica, vol. 36, no. 8, pp. 803–810, 1997. View at Publisher · View at Google Scholar · View at Scopus
  9. K. Nordin, B. Glimelius, L. Påhlman, and P.-U. Sjödén, “Anxiety, depression and worry in gastrointestinal cancer patients attending medical follow-up control visits,” Acta Oncologica, vol. 35, no. 4, pp. 411–416, 1996. View at Publisher · View at Google Scholar · View at Scopus
  10. A. Ballinger, “Gastric leptin,” Gut, vol. 44, no. 2, pp. 153–154, 1999. View at Publisher · View at Google Scholar · View at Scopus
  11. A. Babic, Y. Bao, Z. R. Qian et al., “Pancreatic cancer risk associated with prediagnostic plasma levels of leptin and leptin receptor genetic polymorphisms,” Cancer Research, vol. 76, no. 24, pp. 7160–7167, 2016. View at Publisher · View at Google Scholar
  12. G. H. Bain, E. Collie-Duguid, G. Murray et al., “Tumour expression of leptin is associated with chemotherapy resistance and therapy-independent prognosis in gastro-oesophageal adenocarcinomas,” British Journal of Cancer, vol. 114, no. 12, article e18, 2016. View at Publisher · View at Google Scholar
  13. C. Bjørbæk, S. Uotani, B. Da Silva, and J. S. Flier, “Divergent signaling capacities of the long and short isoforms of the leptin receptor,” Journal of Biological Chemistry, vol. 272, no. 51, pp. 32686–32695, 1997. View at Publisher · View at Google Scholar · View at Scopus
  14. C. Chen, J. Gao, J. Zhang, L. Jia, T. Yu, and Y. Zheng, “Serum leptin level measured 48 h after delivery is associated with development of postpartum depressive symptoms: a 3-month follow-up study,” Archives of Women's Mental Health, vol. 19, no. 6, pp. 1001–1008, 2016. View at Publisher · View at Google Scholar · View at Scopus
  15. M. Laimer, K. Kramer-Reinstadler, M. Rauchenzauner et al., “Effect of mirtazapine treatment on body composition and metabolism,” Journal of Clinical Psychiatry, vol. 67, no. 3, pp. 421–424, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Kloiber, S. Ripke, M. A. Kohli et al., “Resistance to antidepressant treatment is associated with polymorphisms in the leptin gene, decreased leptin mRNA expression, and decreased leptin serum levels,” European Neuropsychopharmacology, vol. 23, no. 7, pp. 653–662, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. T. Qin, F. Fang, M. Song, R. Li, Z. Ma, and S. Ma, “Umbelliferone reverses depression-like behavior in chronic unpredictable mild stress-induced rats by attenuating neuronal apoptosis via regulating ROCK/Akt pathway,” Behavioural Brain Research, vol. 317, pp. 147–156, 2016. View at Publisher · View at Google Scholar
  18. E. Li, H. Deng, B. Wang, W. Fu, Y. You, and S. Tian, “Apelin-13 exerts antidepressant-like and recognition memory improving activities in stressed rats,” European Neuropsychopharmacology, vol. 26, no. 3, pp. 420–430, 2016. View at Publisher · View at Google Scholar · View at Scopus
  19. O. Kwon, K. W. Kim, and M.-S. Kim, “Leptin signalling pathways in hypothalamic neurons,” Cellular and Molecular Life Sciences, vol. 73, no. 7, pp. 1457–1477, 2016. View at Publisher · View at Google Scholar · View at Scopus
  20. H. Cao, Y. Huang, L. Wang et al., “Leptin promotes migration and invasion of breast cancer cells by stimulating IL-8 production in M2 macrophages,” Oncotarget, 2016. View at Publisher · View at Google Scholar
  21. M. Shen and H. Shi, “Estradiol and estrogen receptor agonists oppose oncogenic actions of leptin in HepG2 cells,” PLOS ONE, vol. 11, no. 3, Article ID e0151455, 2016. View at Publisher · View at Google Scholar · View at Scopus
  22. A. M. Wallace, A. Kelly, N. Sattar, C. S. McArdle, and D. C. McMillan, “Circulating concentrations of ‘free" leptin in relation to fat mass and appetite in gastrointestinal cancer patients,” Nutrition and Cancer, vol. 44, no. 2, pp. 156–160, 2002. View at Google Scholar · View at Scopus
  23. F. F. Bolukbas, H. Kilic, C. Bolukbas et al., “Serum leptin concentration and advanced gastrointestinal cancers: A Case Controlled Study,” BMC Cancer, vol. 4, article 29, 2004. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Tessitore, B. Vizio, O. Jenkins et al., “Leptin expression in colorectal and breast cancer patients,” International Journal of Molecular Medicine, vol. 5, no. 4, pp. 421–426, 2000. View at Google Scholar · View at Scopus
  25. M. Kerem, Z. Ferahkose, U. T. Yilmaz et al., “Adipokines and ghrelin in gastric cancer cachexia,” World Journal of Gastroenterology, vol. 14, no. 23, pp. 3633–3641, 2008. View at Publisher · View at Google Scholar · View at Scopus
  26. V. J. Tuominen, S. Ruotoistenmäki, A. Viitanen, M. Jumppanen, and J. Isola, “ImmunoRatio: a publicly available web application for quantitative image analysis of estrogen receptor (ER), progesterone receptor (PR), and Ki-67,” Breast Cancer Research, vol. 12, no. 4, article R56, 2010. View at Publisher · View at Google Scholar · View at Scopus
  27. V. K. Cheruvu and S. C. Oancea, “Current depression as a potential barrier to health care utilization in adult cancer survivors,” Cancer Epidemiology, vol. 44, pp. 132–137, 2016. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Bukberg, D. Penman, and J. C. Holland, “Depression in hospitalized cancer patients,” Psychosomatic Medicine, vol. 46, no. 3, pp. 199–212, 1984. View at Publisher · View at Google Scholar · View at Scopus
  29. M. M. Plumb and J. Holland, “Comparative studies of psychological function in patients with advanced cancer. I. Self-reported depressive symptoms,” Psychosomatic Medicine, vol. 39, no. 4, pp. 264–276, 1977. View at Publisher · View at Google Scholar · View at Scopus
  30. K. Jin Shin, Y. Jin Lee, Y. Ryoul Yang et al., “Molecular mechanisms underlying psychological stress and cancer,” Current Pharmaceutical Design, vol. 22, no. 16, pp. 2389–2402, 2016. View at Publisher · View at Google Scholar
  31. A. Schrepf, S. K. Lutgendorf, and L. M. Pyter, “Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents,” Brain, Behavior, and Immunity, vol. 49, pp. 1–17, 2015. View at Publisher · View at Google Scholar · View at Scopus
  32. G. N. Armaiz-Pena, S. W. Cole, S. K. Lutgendorf, and A. K. Sood, “Neuroendocrine influences on cancer progression,” Brain, Behavior, and Immunity, vol. 30, pp. S19–S25, 2013. View at Publisher · View at Google Scholar · View at Scopus
  33. B. Bortolato, T. N. Hyphantis, S. Valpione et al., “Depression in cancer: the many biobehavioral pathways driving tumor progression,” Cancer Treatment Reviews, vol. 52, pp. 58–70, 2017. View at Publisher · View at Google Scholar
  34. A. K. Sood, G. N. Armaiz-Pena, J. Halder et al., “Adrenergic modulation of focal adhesion kinase protects human ovarian cancer cells from anoikis,” Journal of Clinical Investigation, vol. 120, no. 5, pp. 1515–1523, 2010. View at Publisher · View at Google Scholar · View at Scopus
  35. S. J. Hong, K. W. Kwon, S. G. Kim et al., “Variation in expression of gastric leptin according to differentiation and growth pattern in gastric adenocarcinoma,” Cytokine, vol. 33, no. 2, pp. 66–71, 2006. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Bartha, A. Sayed-Ahmed, and P. Rudas, “Expression of leptin and its receptors in various tissues of ruminants,” Domestic Animal Endocrinology, vol. 29, no. 1, pp. 193–202, 2005. View at Publisher · View at Google Scholar · View at Scopus
  37. Y. Chilliard, M. Bonnet, C. Delavaud et al., “Leptin in ruminants. Gene expression in adipose tissue and mammary gland, and regulation of plasma concentration,” Domestic Animal Endocrinology, vol. 21, no. 4, pp. 271–295, 2001. View at Publisher · View at Google Scholar · View at Scopus
  38. N. Aoki, M. Kawamura, and T. Matsuda, “Lactation-dependent down regulation of leptin production in mouse mammary gland,” Biochimica et Biophysica Acta—General Subjects, vol. 1427, no. 2, pp. 298–306, 1999. View at Publisher · View at Google Scholar · View at Scopus
  39. N. J. Ollberding, Y. Kim, Y. B. Shvetsov et al., “Prediagnostic leptin, adiponectin, C-reactive protein, and the risk of postmenopausal breast cancer,” Cancer Prevention Research, vol. 6, no. 3, pp. 188–195, 2013. View at Publisher · View at Google Scholar · View at Scopus
  40. T. E. Nakajima, Y. Yamada, T. Hamano et al., “Adipocytokines and squamous cell carcinoma of the esophagus,” Journal of Cancer Research and Clinical Oncology, vol. 136, no. 2, pp. 261–266, 2010. View at Publisher · View at Google Scholar · View at Scopus
  41. A. G. Farag, N. F. Elnaidany, and M. M. El-Dien, “Immunohistochemical expression of leptin in non melanoma skin cancer,” Journal of Clinical and Diagnostic Research, vol. 10, no. 8, pp. WC08–WC12, 2016. View at Publisher · View at Google Scholar
  42. G. P. Georgiou, X. Provatopoulou, E. Kalogera et al., “Serum resistin is inversely related to breast cancer risk in premenopausal women,” Breast, vol. 29, pp. 163–169, 2016. View at Publisher · View at Google Scholar · View at Scopus
  43. B. S. Fernandes, S. Dash, F. Jacka et al., “Leptin in bipolar disorder: a systematic review and meta-analysis,” European Psychiatry, vol. 35, pp. 1–7, 2016. View at Publisher · View at Google Scholar · View at Scopus
  44. T. W. Stephens, M. Basinski, P. K. Bristow et al., “The role of neuropeptide Y in the antiobesity action of the obese gene product,” Nature, vol. 377, no. 6549, pp. 530–532, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. C. Garofalo and E. Surmacz, “Leptin and cancer,” Journal of Cellular Physiology, vol. 207, no. 1, pp. 12–22, 2006. View at Publisher · View at Google Scholar · View at Scopus
  46. E. Choi, S.-J. Byeon, S. H. Kim et al., “Implication of leptin-signaling proteins and epstein-barr virus in gastric carcinomas,” PLoS ONE, vol. 10, no. 7, Article ID e0130839, 2015. View at Publisher · View at Google Scholar · View at Scopus